Aaron I. Davis
CIK 1465914 · last filed 2024-10-28
Aaron I. Davis is a corporate insider who has filed 45 SEC Form 4 insider transactions across 6 companies since 2017. The most recent filing shows the insider sold $8.7M of TNGX on Oct 28, 2024. Across all open-market trades the lifetime net is +$118.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $391.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$391.12M
6
45
$118.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNGX | Director | 6,799,435 | $30.94 | $210.37M | $5.59M | 8 | 2024-10-28 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | 4,815,754 | $10.15 | $48.88M | -$18.27M | 11 | 2024-06-13 |
| TYRA | 10%+ Owner | 6,534,298 | $26.99 | $176.36M | $43.00M | 3 | 2024-02-08 |
| RAIN | Director | 2,147,212 | $2.04 | $4.38M | $45.36M | 5 | 2024-01-26 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 1,572,368 | $58.70 | $92.30M | -$2.38M | 9 | 2024-01-23 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 5,232,842 | $1.12 | $5.86M | $44.99M | 9 | 2021-11-19 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-28 | TNGX | Sell (S) | −1,266,000 | -$8.70M | EDGAR |
| 2024-09-05 | TNGX | Other (J) | — | $0 | EDGAR |
| 2024-06-13 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-03 | TNGX | Sell (S) | −420,000 | -$3.16M | EDGAR |
| 2024-02-08 | TYRA | Grant (A) | +317,060 | $4.12M | EDGAR |
| 2024-01-26 | RAIN | Mixed | −79,726 | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −54,325 | $0 | EDGAR |
| 2024-01-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +6,808 | $400.0K | EDGAR |
| 2023-10-11 | TNGX | Grant (A) | +2,375,000 | $12.23M | EDGAR |
| 2023-08-25 | iTeos Therapeutics, Inc. (ITOS) Delisted | Sell (S) | −1,400,000 | -$22.77M | EDGAR |